Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PrEP and Timed Intercourse for HIV-Discordant Couples
NCT02572505Withdrawn
- Sponsor
- University of Missouri
- Start
- Nov 2015
- Primary completion
- Sep 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of emtricitabine + tenofovir disoproxil in human immunodeficiency virus infection (HIV), sponsored by University of Missouri. Primary endpoint: Proportion of women remaining HIV-seronegative at 6 months. Planned start Nov 2015; status: withdrawn.
02
Drugs
emtricitabine + tenofovir disoproxil
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT02572505.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02572505.